维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Assersohn L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast --enhanced MR imaging显示文摘	Padhani AR Hayes C Assersohn L	2006	Radiology2006，239，2：	1
2	Phase Ⅱ study of irinotecan and 5-fluorouracil/ leucovorin in patients with primarv refractory or relapsed advanced oesophageal and gastric carcinoma显示文摘	Assersohn L Brown G Cunningham D	2004	Ann Oncol2004，15，1：	1
3	Prediction of clinico pathologic response of breast cancer to primary chemotherapy at contrast enhanced MR imaging :initial clinical results显示文摘	Padhanni AR Hayes C Assersohn L	2006	Radiio logy2006，239，9：	1
4	A phase Ⅱ trial evalua-ting capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on,or within 3 months of platinum-based chemotherapy显示文摘	Leary A Assersohn L Cunningham D		0，，03：	1
5	Phase Ⅱ study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma显示文摘	ASSERSOHN L BROWN G CUNNINGHAM D	2004	Ann Oncol2004，15，1：	1
6	Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results显示文摘	Padhani AR Hayes C Assersohn L	2006	Radiology2006，239，：	1
7	Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging:initial clinical results显示文摘	Padhani AR Hayes C Assersohn L	2006	Radiology2006，239，2：	1
8	Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging显示文摘	Padhani AR Hayes C Assersohn L	2006	Radiology2006，239，2：	1
9	A randomized pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy显示文摘	Assersohn L Souberbielle BE OBrien ME	2002	Clin On-col2002，14，1：	1
10	Hormone replace-ment therapy and women with premature menopause-acancer survivorship issue显示文摘	King J Wynne CH Assersohn L	2011	Eur J Cancer2011，47，11：	1
11	Hormone replace-ment therapy and women with premature menopause--acancer survivorship issue显示文摘	King J Wynne CH Assersohn L	2011	Eur J Cancer2011，47，11：	1
12	Phase Ⅱ study of irinotecan and 5 -fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma显示文摘	Assersohn L Brown G Cunningham D	2004	Ann Oncol2004，15，1：	1
13	Prediction of clinico-pathologic response of breast cancer to primary chemotherapy atcontrast-enhanced MR imaging : initial clinical results 显示文摘	Padhani AR Hayes C Assersohn L	2006	Radiol-ogy2006，239，2：	1
14	Phase Ⅱstudy of irinotecan and 5-fluoracil/leucovorin in patients with primary refractory or relapsed advanced oesphageal and gastric carcinoma显示文摘	Assersohn L Brown G Cunningham D	2004	Ann Oncol2004，15，1：	1
15	Hormone replacement therapy and women with premature menopause-a cancer survivorship issue 显示文摘	King J Wynne CH Assersohn L	2011	Eur J Cancer2011，47，11：	1
16	Studies of the potential utility of Ki - 67 as a predictive molecular marker of clinical response in primary breast cancer 显示文摘	Assersohn L Salter J Powles TJ	2003	Breast Cancer Research and Treatment2003，82，：	1
17	Phase Ⅱ study of irinotecan and 5 - fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma显示文摘	Assersohn L Brown G Cunningham D	2004	Ann Oncol2004，15，：	1
18	Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma显示文摘	Assersohn L Brown G Cunningham D	2004	Ann Oncol2004，15，1：	1
19	Phase II study of irinotecan and 5-fluorouracil/leucovorin in pa- tients with primary refractory or relapsed advanced oe- sophageal and gastric carcinoma显示文摘	Assersohn L Brown G Cunningham D	2004	Ann Oncol2004，15，1：	1
20	A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of plati- num- based chemotherapy显示文摘	Leary A Assersohn L Cunningham D	2009	Cancer Chemother Phar- macol2009，64，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示